{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:56:51Z","timestamp":1786993011364,"version":"build-2736575974"},"reference-count":115,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jns.2015.08.1544","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T05:27:24Z","timestamp":1441171644000},"page":"9-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Scales for hyperkinetic disorders: A systematic review"],"prefix":"10.1016","volume":"358","author":[{"given":"Sara","family":"Pietracupa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea E.","family":"Cavanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Falla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Zappia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Colosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2015.08.1544_bb0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrneurol.2009.196","article-title":"The clinical approach to movement disorders","volume":"6","author":"Abdo","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2015.08.1544_bb0010","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/mds.25579","article-title":"Dystonia rating scales: critique and recommendations","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0015","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/jnnp.56.8.868","article-title":"Assessing tremor severity","volume":"56","author":"Bain","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.33.3.296","article-title":"Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial","volume":"33","author":"Baruzzi","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0025","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/01.mlg.0000233255.57425.36","article-title":"Development and validation of the vocal tremor scoring system","volume":"116","author":"Bov\u00e9","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jns.2015.08.1544_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","article-title":"Validity and reliability of a rating scale for the primary torsion dystonias","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0035","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1212\/01.WNL.0000142962.11881.26","article-title":"Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58).","volume":"63","author":"Cano","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0040","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/01.wnl.0000249310.25427.f2","article-title":"CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia","volume":"67","author":"Cano","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-6-58","article-title":"The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?","volume":"6","author":"Cano","year":"2008","journal-title":"Health Qual. Life Outcomes"},{"issue":"8","key":"10.1016\/j.jns.2015.08.1544_bb0050","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S0022215109005398","article-title":"Measuring voice outcomes: state of the science review","volume":"123","author":"Carding","year":"1999","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0055","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1212\/01.wnl.0000327890.02893.61","article-title":"The Gilles de la Tourette Syndrome-Quality of Life scale (GTS-QOL): development and validation","volume":"71","author":"Cavanna","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0060","article-title":"Clinical rating instruments in Tourette syndrome","author":"Cavanna","year":"2013","journal-title":"Oxf. Med."},{"key":"10.1016\/j.jns.2015.08.1544_bb0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/brain\/100.3.455","article-title":"Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam","volume":"100","author":"Chadwick","year":"1977","journal-title":"Brain"},{"key":"10.1016\/j.jns.2015.08.1544_bb0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2005.02.013","article-title":"Manual for the Extrapyramidal Symptom Rating Scale (ESRS)","volume":"76","author":"Chouinard","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jns.2015.08.1544_bb0080","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.23072","article-title":"Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations","volume":"25","author":"Colosimo","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10377","article-title":"Rating scales for dystonia: a multicenter assessment","volume":"18","author":"Comella","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2011.05.041","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN ((R)), botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia","volume":"308","author":"Comella","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2015.08.1544_bb0095","series-title":"Therapy with Botulinum Toxin","first-page":"211","article-title":"Clinical Assessments of Patients with Cervical Dystonia","author":"Consky","year":"1994"},{"key":"10.1016\/j.jns.2015.08.1544_bb0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.otohns.2004.02.048","article-title":"Short, self-report voice symptom scales: psychometric characteristics of the Voice Handicap Index-10 and the Vocal Performance Questionnaire","volume":"131","author":"Deary","year":"2004","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jns.2015.08.1544_bb0105","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(11)70233-2","article-title":"Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"De Yebenes","year":"2011","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jns.2015.08.1544_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.wnf.0000240945.44370.f0","article-title":"Two years' follow-up of rivastigmine treatment in Huntington disease","volume":"30","author":"de Tommaso","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0115","series-title":"Clinical Rating Scale for Tremor","first-page":"271","article-title":"Parkinson's disease and movement disorders","author":"Fahn","year":"1993"},{"key":"10.1016\/j.jns.2015.08.1544_bb0120","first-page":"3","article-title":"Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia","volume":"17","author":"Fernandez","year":"2013"},{"key":"10.1016\/j.jns.2015.08.1544_bb0125","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.35.12.1784","article-title":"Phenobarbitone in essential tremor","volume":"35","author":"Findley","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0130","doi-asserted-by":"crossref","first-page":"M206","DOI":"10.1093\/gerona\/51A.5.M206","article-title":"Functional decline in older adults: expanding methods of ascertainment","volume":"51","author":"Fried","year":"1996","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jns.2015.08.1544_bb0135","first-page":"361","article-title":"The Unified Myoclonus Rating Scale","volume":"89","author":"Frucht","year":"2002","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0140","series-title":"Global Tic Rating Scale","author":"Gadow","year":"1986"},{"key":"10.1016\/j.jns.2015.08.1544_bb0145","first-page":"269","article-title":"The MOVES: a self-rating scale for Tourette's syndrome","volume":"4","author":"Gaffney","year":"1994","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jns.2015.08.1544_bb0150","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0155","series-title":"Abnormal Involuntary Movement Scale","first-page":"534","article-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.jns.2015.08.1544_bb0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0447.2009.01398.x","article-title":"Adults with Tourette's syndrome with and without attention deficit hyperactivity disorder","volume":"120","author":"Haddad","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.jns.2015.08.1544_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/WNF.0b013e3181ebd109","article-title":"A pilot efficacy and tolerability trial of memantine for essential tremor","volume":"33","author":"Handforth","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00004583-198403000-00006","article-title":"A new instrument for clinical studies of Tourette's syndrome","volume":"23","author":"Harcherik","year":"1984","journal-title":"J. Am. Acad. Child Psychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0175","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0003-9993(98)90174-5","article-title":"Rater reliability of Fahn's Tremor Rating Scale in patients with multiple sclerosis","volume":"79","author":"Hooper","year":"1998","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.jns.2015.08.1544_bb0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Reliability and consistency. Huntington Study Group","volume":"11","author":"Unified Huntington's Disease Rating Scale","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0185","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/mds.25362","article-title":"A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease","volume":"28","author":"Huntington Study Group HART Investigators","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mds.10671","article-title":"Quantification of focal dystonia in pianists using scale analysis","volume":"19","author":"Jabusch","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1044\/1058-0360.0603.66","article-title":"The Voice Handicap Index (VHI): development and validation","volume":"6","author":"Jacobson","year":"1997","journal-title":"Am. J. Speech Lang. Pathol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/schbul\/8.2.267","article-title":"The epidemiology of Tourette's syndrome: a pilot study","volume":"8","author":"Jagger","year":"1982","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jns.2015.08.1544_bb0205","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.22368","article-title":"Relationship between various clinical outcome assessments in patients with blepharospasm","volume":"24","author":"Jankovic","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0215","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jnnp.42.9.831","article-title":"Relationship between plasma propranolol concentration and relief of essential tremor","volume":"42","author":"Jefferson","year":"1979","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0220","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","article-title":"Acute and chronic effects of propranolol and primidone in essential tremor","volume":"39","author":"Koller","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0733-8619(05)70309-1","article-title":"Tourette syndrome. Clinical rating and quantitative assessment of tics","volume":"15","author":"Kompoliti","year":"1997","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jns.2015.08.1544_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2011.01.007","article-title":"1-Hz low frequency repetitive transcranial magnetic stimulation in children with Tourette's syndrome","volume":"492","author":"Kwon","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2015.08.1544_bb0235","series-title":"Tourette Syndrome Unified Rating Scale","author":"Kurlan","year":"1988"},{"key":"10.1016\/j.jns.2015.08.1544_bb0240","series-title":"Handbook of Tourette's Syndrome and Related tic and Behavioral Disorders","article-title":"Rating tic severity","author":"Kurlan","year":"2005"},{"key":"10.1016\/j.jns.2015.08.1544_bb0245","series-title":"Tourette's Syndrome and tic Disorders: Clinical Understanding and Treatment","article-title":"Clinical assessment of tic disorder severity","author":"Leckman","year":"1988"},{"key":"10.1016\/j.jns.2015.08.1544_bb0250","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0255","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/00207451003668408","article-title":"RimabotulinumtoxinB effects on pain associated with cervical dystonia: results of placebo and comparator-controlled studies","volume":"120","author":"Lew","year":"2010","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jns.2015.08.1544_bb0260","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mds.870100407","article-title":"The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm","volume":"10","author":"Lindeboom","year":"1995","journal-title":"Mov. Disord."},{"issue":"S44","key":"10.1016\/j.jns.2015.08.1544_bb0265","first-page":"5","article-title":"Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale","volume":"55","author":"Lindstr\u00f6m","year":"2001","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000109681","article-title":"The Washington Heights-Inwood Genetic Study of Essential Tremor: methodological issues in essential-tremor research","volume":"16","author":"Louis","year":"1997","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0275","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1212\/WNL.50.5.1351","article-title":"Does a screening questionnaire for essential tremor agree with the physicians' examination?","volume":"50","author":"Louis","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0280","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.870130215","article-title":"Reliability between two observers using a protocol for diagnosing essential tremor","volume":"13","author":"Louis","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0285","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archneur.56.7.841","article-title":"Validity of a performance-based test of function in essential tremor","volume":"56","author":"Louis","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1531-8257(200101)16:1<89::AID-MDS1001>3.0.CO;2-L","article-title":"A teaching videotape for the assessment of essential tremor","volume":"16","author":"Louis","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0295","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1192\/bjp.158.3.323","article-title":"Motor, volitional and behavioural disorders in schizophrenia. 1: assessment using the Modified Rogers Scale","volume":"158","author":"Lund","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0300","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1615\/CritRevBiomedEng.v35.i5.10","article-title":"A review on techniques for tremor recording and quantification","volume":"35","author":"Mansur","year":"2007","journal-title":"Crit. Rev. Biomed. Eng."},{"key":"10.1016\/j.jns.2015.08.1544_bb0305","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2125.1981.tb01118.x","article-title":"Assessment of extrapyramidal disorders","volume":"11","author":"Marsden","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0310","series-title":"Parkinson Disease and Other Movement Disorders: Motor Behavioural Disorders and Behavioural Motor Disorders","article-title":"Scales and tests in movement disorders","author":"Mart\u00ednez-Mart\u00edn","year":"2014"},{"key":"10.1016\/j.jns.2015.08.1544_bb0315","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1749-4486.2010.02194.x","article-title":"Oromandibular dystonia questionnaire (OMDQ-25): a valid and reliable instrument for measuring health-related quality of life","volume":"35","author":"Merz","year":"2010","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0320","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jvoice.2010.07.011","article-title":"A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia","volume":"26","author":"Morzaria","year":"2012","journal-title":"J. Voice"},{"key":"10.1016\/j.jns.2015.08.1544_bb0325","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.10473","article-title":"The Unified Parkinson\u2019s Disease Rating Scale (UPDRS): status and recommendations","volume":"18","author":"Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0330","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.2003.013441","article-title":"Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease specific quality of life instrument","volume":"75","author":"M\u00fcller","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette's syndrome with delta 9-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"M\u00fcller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0340","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/brain\/124.4.769","article-title":"Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia","volume":"124","author":"M\u00fcnchau","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jns.2015.08.1544_bb0345","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000036615.25044.50","article-title":"Repetitive transcranial magnetic stimulation for Tourette syndrome","volume":"59","author":"M\u00fcnchau","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0350","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF02168939","article-title":"Observations and ratings of tics in school settings","volume":"22","author":"Nolan","year":"1994","journal-title":"J. Abnorm. Child Psychol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0355","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00314194","article-title":"Comparative studies on the effects of beta-adrenergic blockers in essential tremor","volume":"235","author":"Ogawa","year":"1987","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0360","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00002826-200211000-00003","article-title":"Tetrabenazine treatment for Huntington's disease-associated chorea","volume":"25","author":"Ondo","year":"2002","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0365","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.clinph.2004.10.003","article-title":"Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome","volume":"116","author":"Orth","year":"2005","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0370","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/mds.21234","article-title":"Quality of life in focal, segmental, and generalized dystonia","volume":"22","author":"Page","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0375","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/WNL.0b013e3181bd809b","article-title":"Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome","volume":"73","author":"Porta","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0380","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1469-8749.2008.03168.x","article-title":"Understanding disability in Tourette syndrome","volume":"51","author":"Pringsheim","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0385","first-page":"CD006996","article-title":"Pimozide for tics in Tourette's syndrome","volume":"2","author":"Pringsheim","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2015.08.1544_bb0390","first-page":"CD007990","article-title":"Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders","volume":"4","author":"Pringsheim","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2015.08.1544_bb0395","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.57.3.405","article-title":"Limb immobilization for the treatment of focal occupational dystonia","volume":"57","author":"Priori","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0400","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1212\/WNL.53.9.2108","article-title":"The Tourette syndrome diagnostic confidence index: development and clinical association","volume":"53","author":"Robertson","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0405","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","article-title":"Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder","volume":"154","author":"Sallee","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0410","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1176\/jnp.5.1.56","article-title":"Reliability and applicability of movement disorders rating scales in the elderly","volume":"5","author":"Seet","year":"1993","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jns.2015.08.1544_bb0415","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00004583-198403000-00007","article-title":"Controlled study of pimozide vs. placebo in Tourette's syndrome","volume":"23","author":"Shapiro","year":"1984","journal-title":"J. Am. Acad. Child Psychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0420","series-title":"Gilles de la Tourette Syndrome","first-page":"451","article-title":"Measurement in tic disorders","author":"Shapiro","year":"1988"},{"key":"10.1016\/j.jns.2015.08.1544_bb0425","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1073191103255497","article-title":"The Tourette's Disorder Scale (TODS): development, reliability, and validity","volume":"10","author":"Shytle","year":"2003","journal-title":"Assessment"},{"key":"10.1016\/j.jns.2015.08.1544_bb0430","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00496058","article-title":"A rating scale for tardive dyskinesia","volume":"64","author":"Simpson","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0435","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.95.1.74","article-title":"The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine","volume":"95","author":"Singer","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.jns.2015.08.1544_bb0440","first-page":"266","article-title":"A rating scale for tardive dyskinesia and parkinsonian symptoms","volume":"19","author":"Smith","year":"1983","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jns.2015.08.1544_bb0445","first-page":"328","article-title":"The dyskinesia identification system\u2014Coldwater (DIS-Co): a tardive dyskinesia rating scale for the developmentally disabled","volume":"20","author":"Sprague","year":"1984","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jns.2015.08.1544_bb0450","first-page":"51","article-title":"Reliability, validity, and a total score cutoff for the dyskinesia identification system: condensed user scale (DISCUS) with mentally ill and mentally retarded populations","volume":"27","author":"Sprague","year":"1991","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jns.2015.08.1544_bb0455","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mds.21412","article-title":"Assessment of interrater and intrarater reliability of the Fahn\u2013Tolosa\u2013Marin Tremor Rating Scale in Essential Tremor","volume":"22","author":"Stacy","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0460","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00702-009-0353-3","article-title":"Tic disorders and the premonitory urge","volume":"117","author":"Steinberg","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jns.2015.08.1544_bb0465","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0892-1997(97)80029-X","article-title":"Adductor spasmodic dysphonia: standard evaluation of symptoms and severity","volume":"11","author":"Stewart","year":"1997","journal-title":"J. Voice"},{"key":"10.1016\/j.jns.2015.08.1544_bb0470","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10578-004-1880-7","article-title":"Further psychometric properties of the Tourette's Disorder Scale-Parent Rated version (TODS-PR)","volume":"35","author":"Storch","year":"2004","journal-title":"Child Psychiatry Hum. Dev."},{"key":"10.1016\/j.jns.2015.08.1544_bb0475","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1037\/1040-3590.17.4.486","article-title":"Reliability and validity of the Yale Global Tic Severity Scale","volume":"17","author":"Storch","year":"2005","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.jns.2015.08.1544_bb0480","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.psychres.2006.03.017","article-title":"Factor-analytic study of the Yale Global Tic Severity Scale","volume":"149","author":"Storch","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jns.2015.08.1544_bb0485","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10578-006-0043-4","article-title":"Further psychometric examination of the Tourette\u2019s Disorder Scales","volume":"38","author":"Storch","year":"2007","journal-title":"Child Psychiatry Hum. Dev."},{"key":"10.1016\/j.jns.2015.08.1544_bb0490","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/cap.2010.0149","article-title":"Defining treatment response in pediatric tic disorders: a signal detection analysis of the Yale Global Tic Severity Scale","volume":"21","author":"Storch","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0495","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2008.03.009","article-title":"Prevalence of essential tremor: a door-to-door survey in Sile, Istanbul, Turkey","volume":"15","author":"Sur","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0500","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1100\/tsw.2011.57","article-title":"Sensory gating scales and premonitory urges in Tourette syndrome","volume":"11","author":"Sutherland Owens","year":"2011","journal-title":"Sci. World J."},{"key":"10.1016\/j.jns.2015.08.1544_bb0505","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1212\/WNL.24.1.64","article-title":"Propranolol treatment of essential tremor","volume":"24","author":"Sweet","year":"1974","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.08.1544_bb0510","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mds.20377","article-title":"UFMG Sydenham's chorea rating scale (USCRS): reliability and consistency","volume":"20","author":"Teixeira","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0515","first-page":"499","article-title":"Ondansentron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study","volume":"66","author":"Toren","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0520","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/mds.870030306","article-title":"Therapeutic trial with glycine in myoclonus","volume":"3","author":"Truong","year":"1988","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0525","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1017\/S031716710003540X","article-title":"A pilot study on the use of botulinum toxin in spasmodic torticollis","volume":"12","author":"Tsui","year":"1985","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2015.08.1544_bb0530","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2015.08.1544_bb0535","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1017\/S0317167100038063","article-title":"Local treatment of spasmodic torticollis with botulinum toxin","volume":"14","author":"Tsui","year":"1987","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2015.08.1544_bb0540","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jnnp.63.1.35","article-title":"Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study","volume":"63","author":"Van Vugt","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2015.08.1544_bb0545","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/mds.21718","article-title":"Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: a double blind, randomized cross-over trial","volume":"22","author":"Vitale","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2015.08.1544_bb0550","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00004583-199205000-00013","article-title":"The validity of instruments measuring tic severity in Tourette's syndrome","volume":"31","author":"Walkup","year":"1992","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2015.08.1544_bb0555","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nurt.2009.10.003","article-title":"Validation of the modified motor score (mMS): a subscale of the Unified Huntington\u2019s Disease Rating Scale (UHDRS) motor score","volume":"7","author":"Waters","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jns.2015.08.1544_bb0560","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1017\/S0022215107007177","article-title":"Optimising outcome assessment of voice interventions, I: reliability and validity of three self-reported scales","volume":"121","author":"Webb","year":"2007","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.jns.2015.08.1544_bb0565","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00006199-198305000-00005","article-title":"Development of a screening program for tardive dyskinesias: feasibility issue","volume":"32","author":"Whall","year":"1983","journal-title":"Nurs. Res."},{"key":"10.1016\/j.jns.2015.08.1544_bb0570","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00004703-200512000-00001","article-title":"Premonitory Urge for Tics Scale (PUTS): initial psychometric results and examination of the premonitory urge phenomenon in youths with tic disorders","volume":"26","author":"Woods","year":"2005","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.jns.2015.08.1544_bb0575","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1600-0404.2008.01111.x","article-title":"Impact of dystonia on quality of life and health in a Swedish population","volume":"119","author":"Zetterberg","year":"2009","journal-title":"Acta Neurol. Scand."},{"issue":"12","key":"10.1016\/j.jns.2015.08.1544_bb8000","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/mds.25162","article-title":"Reliability of a new scale for essential tremor","volume":"27","author":"Elble","year":"2008","journal-title":"Mov. Disord."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15020407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15020407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T02:32:38Z","timestamp":1653100358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X15020407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":115,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0022510X15020407"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2015.08.1544","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scales for hyperkinetic disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2015.08.1544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}